✦ LIBER ✦

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

✍ Scribed by Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; Lynda C. Schneider; Richard L. Wasserman; Borislava G. Pavlova; Karl Birthistle; Marianne Mancini; Sandor Fritsch; Lisa Patrone; Kerry Moore-Perry; Hartmut J. Ehrlich; the US-PID-IGIV 10% -Study Group10

Publisher: Springer
Year: 2006
Tongue: English
Weight: 443 KB
Volume: 26
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-006-9025-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, Safety, and Pharmacokinetics o

Efficacy, Safety, and Pharmacokinetics of a 10% Liquid Immune Globulin Preparation (GAMMAGARD LIQUID, 10%) Administered Subcutaneously in Subjects with Primary Immunodeficiency Disease

✍ Richard L. Wasserman; Isaac Melamed; Lisa Kobrynski; Steven D. Strausbaugh; Mark 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 213 KB

Safety and Efficacy of Privigen®, a Nove

Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies

✍ Mark R. Stein; Robert P. Nelson; Joseph A. Church; Richard L. Wasserman; Michael 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 166 KB

Efficacy, Pharmacokinetics, Safety, and

Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency

✍ Melvin Berger; Paul J. Pinciaro; Arthur Althaus; Mark Ballow; Akhilesh Chouksey; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Efficacy and Tolerability of an Argentin

Efficacy and Tolerability of an Argentine Intravenous Immunoglobulin in Pediatric Patients with Primary Immunodeficiency Diseases

✍ S. Krasovec; A. Ornani; M. Oleastro; S. Rosenzweig; A. Roy; L. Perez; G. Campos; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 175 KB

Efficacy and Safety of a New 20% Immunog

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

✍ John B. Hagan; Mary B. Fasano; Sheldon Spector; Richard L. Wasserman; Isaac Mela 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB

Efficacy and Safety of Hizentra®, a New

Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency

✍ Michael Borte; Malgorzata Pac; Margit Serban; Teresa Gonzalez-Quevedo; Bodo Grim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 182 KB